Moneycontrol
HomeNewsBusinessEconomyRural demand can support, but not substitute for falling urban consumption in FY21: Report
Trending Topics

Rural demand can support, but not substitute for falling urban consumption in FY21: Report

The COVID-19-led business disruptions during end-March-May 2020 have been so severe that the Indian economy shrank 23.9 percent during the April-June quarter this year, confirming fears of a crippling slide across several industries and services

September 07, 2020 / 16:12 IST
Story continues below Advertisement

Representative image

Rural demand in FY 2020-21 can at best can extend support to consumption demand, but cannot be a substitute for urban demand, a study by India Ratings and Research and Research has found.

"Any two or three consecutive good harvests generally translate into a robust rural demand. So, the hope is that while the industrial and services sectors are still struggling to recover from the adverse impact of COVID-19, the agricultural sector could become an engine for economic recovery," the report said.

Story continues below Advertisement

Despite encouraging sales number of motorcycles and tractors in June 2020, a large part of the rural demand comes from consumer non-durables. In the use-based Index of Industrial Production classification data, the first category to record positive growth in the post lockdown period is consumer non-durables, which grew 14 percent year-on-year in June 2020.

"Since the share of agriculture in India’s gross value added is about 17 percent, Ind-Ra believes rural demand at best can extend support to the consumption demand, but cannot be a substitute for urban demand," the report said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show